Provided by Tiger Trade Technology Pte. Ltd.

ARK Genomic Revolution ETF

48.41
-1.7300-3.45%
Volume:3.27M
Turnover:158.94M
Market Cap:2.08B
PE:- -
High:49.49
Open:49.16
Low:48.30
Close:50.14
52wk High:58.83
52wk Low:24.60
Shares:43.05M
Float Shares:43.05M
Volume Ratio:1.19
T/O Rate:7.59%
Dividend:- -
Dividend Rate:- -
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Qnity Electronics to showcase portfolio at TPCA Show

TIPRANKS
·
Oct 05

Press Release: Greenland Mines Doubles AnorTech Stake to 19.9%; Extends Critical-Minerals Platform to Smelter-Grade Alumina, Lunar Construction Materials

Dow Jones
·
Oct 05

Building trust, transparency and risk management in battery raw materials markets

Fastmarkets
·
Oct 05

Entropy Neurodynamics posts 2026 AGM materials and streamlines investor communications

TIPRANKS
·
Oct 05

Cathie Wood: Smart Investors Need to Start Watching Where AI Agents Spend Their Money

Deep News
·
Oct 04

Twist Bioscience (TWST) Rallies As Growth Narrative Tests Whether The Stock Is Already Pricey

Simply Wall St.
·
Oct 04

One Weekend, Thousands Of Compounds: Inside Microsoft's New AI Biology Model

AI Industry Frontlines
·
Oct 03

10x Genomics (TXG) Could Be 50% Above Fair Value On Sentira And Atera Launches

Simply Wall St.
·
Oct 03

Crispr Therapeutics Presents Phase 1 Zugo-Cel Data in Refractory Systemic Sclerosis at ACR Convergence 2026

Reuters
·
Oct 02

Zojirushi Outlines 2026 Financial Results, Forecast and Shareholder Returns

TIPRANKS
·
Oct 02

Op-Ed: The energy transition is starting to feed itself

Mining
·
Oct 02

CRISPR Therapeutics (CRSP) Stock May Command A Premium On Its Equity Base

Simply Wall St.
·
Oct 02

ETF Daily | COHX, COHH, COHC Soar 22%; SOXL, DIG Rally 4%; AAOZ Sinks 16%; Optical Communications Rally Leads

ETF Tracker
·
Oct 02

Maas Group completes $1.61bn sale of construction materials arm to Heidelberg

TIPRANKS
·
Oct 02

H.C. Wainwright Remains a Buy on AbSci (ABSI)

TIPRANKS
·
Oct 01

Twist Bioscience is Maintained at Buy by Guggenheim

Dow Jones
·
Oct 01

Tempus AI price target raised to $92 from $65 at Guggenheim

TIPRANKS
·
Oct 01

Twist Bioscience price target raised to $212 from $107 at Guggenheim

TIPRANKS
·
Oct 01

Tempus AI Says 13 Clinical Research Abstracts Win ESMO 2026 Presentation Slots

Reuters
·
Oct 01

Tempus Announces 13 Abstracts Accepted for Presentation at the European Society for Medical Oncology Congress 2026

THOMSON REUTERS
·
Oct 01